https://www.selleckchem.com/pr....oducts/irpagratinib.
te the dynamic pathological changes within the irradiated salivary glands. 1 TECHNICAL EFFICACY Stage 2. 1 TECHNICAL EFFICACY Stage 2. Previous microbiome studies of oropharyngeal cancer have shown that there are differences in the oral microbiota between human papillomavirus (HPV)-positive and HPV-negative patients. We collected saliva, normal tissue, and tumor biopsies from 13 patients with oropharyngeal cancer (eight HPV-positive, five HPV-negative). We obtained basic clinical data from each patient. Extracted DNA was 16S rRNA g